Healthcare - Biotechnology - NASDAQ - US
$ 12.43
-3.27 %
$ 756 M
Market Cap
-3.71
P/E
BALANCE SHEET
512 M
ASSETS
38.6 M
LIABILITIES
474 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Pliant Therapeutics, Inc.
| Current Assets | 506 M |
| Cash & Short-Term Investments | 494 M |
| Receivables | 3 M |
| Other Current Assets | 8.26 M |
| Non-Current Assets | 6.65 M |
| Long-Term Investments | 0 |
| PP&E | 4.78 M |
| Other Non-Current Assets | 1.87 M |
| Current Liabilities | 28.5 M |
| Accounts Payable | 4.53 M |
| Short-Term Debt | 2.64 M |
| Other Current Liabilities | 21.4 M |
| Non-Current Liabilities | 10.1 M |
| Long-Term Debt | 10.1 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 63.2 | 33.7 | 51.7 | 50.9 | 85.8 | 60.9 | 4.3 |
| Short Term Investments | 431.0 | 297.5 | 148.9 | 226.0 | 17.0 | 0 | 0 |
| Receivables | 3.0 | 2.0 | 2.0 | 9.4 | 7.4 | 0.5 | 0 |
| Inventory | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.3 | 7.1 | 6.8 | 4.5 | 1.7 | 0.3 | 0.5 |
| Total Current Assets | 505.5 | 340.3 | 209.4 | 290.8 | 111.9 | 61.7 | 4.7 |
| PP&E | 4.8 | 9.9 | 10.9 | 4.3 | 4.1 | 4.3 | 1.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.9 | 0.4 | 0.8 | 0.5 | 3.1 | 0.5 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 512.2 | 350.6 | 221.2 | 295.5 | 119.1 | 66.5 | 6.6 |
| LIABILITIES | |||||||
| Accounts Payable | 4.5 | 1.6 | 3.0 | 2.0 | 1.2 | 2.6 | 1.6 |
| Short Term Debt | 2.6 | 4.9 | 3.7 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.4 | 17.4 | 10.1 | 9.6 | 6.9 | 2.5 | 1.6 |
| Total Current Liabilities | 28.5 | 23.9 | 16.8 | 11.6 | 8.2 | 5.1 | 3.2 |
| Long Term Debt | 10.1 | 13.4 | 5.3 | 0 | 0.9 | 1.1 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0.9 | 110.4 | 61.3 | 0 |
| Total Liabilities | 38.6 | 37.3 | 22.2 | 12.5 | 119.5 | 67.4 | 3.2 |
| EQUITY | |||||||
| Common Stock | 6 K | 5 K | 3 K | 3 K | 1 K | 1 K | 1 K |
| Retained Earnings | (499.7) | (338.4) | (215.1) | (117.8) | (76.3) | (71.5) | (36.6) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | (2.0) | (0.2) | 32 K | 1 K | (1.1) | 0 |
| Total Equity | 473.6 | 313.3 | 199.1 | 283.1 | (0.4) | (0.9) | 3.3 |
| Total Liabilities and Equity | 512.2 | 350.6 | 221.2 | 295.5 | 119.1 | 66.5 | 6.5 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 58.7 | 42.0 | 35.8 | 35.6 | 35.6 | 16.5 | 0.8 |